The Long Run with Luke Timmerman podcast

Ep189: Marc Tessier-Lavigne on Reinventing Drug Discovery with AI

12/11/2025

The Long Run with Luke Timmerman

0:00

1:12:33

Marc Tessier-Lavigne, CEO of South San Francisco-based Xaira Therapeutics, on reinventing drug discovery with AI.

D'autres épisodes de "The Long Run with Luke Timmerman"

Ep190: Neil Kumar on Building a Rare Disease Drug Company
20/11/2025
1:13:12
Neil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.
Ep189: Marc Tessier-Lavigne on Reinventing Drug Discovery with AI
12/11/2025
1:12:33
Marc Tessier-Lavigne, CEO of South San Francisco-based Xaira Therapeutics, on reinventing drug discovery with AI.
Ne ratez aucun épisode de “The Long Run with Luke Timmerman” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.
Ep188: Art Krieg on Innate Immune System Activators for Cancer
28/10/2025
1:09:05
Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.
Ep187: Eric Fischer on Creating a New Class of Medicines
14/10/2025
1:05:48
Eric Fischer, a professor at Dana-Farber Cancer Institute, on creating a new class medicines -- targeted protein degraders.
Ep186: Bruce Levine & Mags McCarthy on a Song About Science and Hope
29/09/2025
1:02:33
Bruce Levine, a CAR-T cell therapy researcher at the University of Pennsylvania, and Mags McCarthy, a country music star, discuss their new song about science and hope for cancer patients.
Ep185: Dr. Lachelle Weeks on Predicting Leukemia Risk At Scale
17/09/2025
1:05:47
Dr. Lachelle Weeks is a physician-scientist at Dana-Farber Cancer Institute working on a project to predict leukemia risk based on widely available blood samples.
Ep184: Jen Adair on Affordable, Accessible Gene & Cell Therapies
28/08/2025
1:50:23
Jen Adair, professor and associate director of the Horae Gene Therapy Center at the University of Massachusetts Chan Medical School, on creating more affordable and accessible cell and gene therapies.
Ep183: Sabah Oney on CAR-T Cells Against Solid Tumors
06/08/2025
56:23
Sabah Oney, CEO of Philadelphia and San Francisco-based Dispatch Biotherapeutics, on engineering CAR-T cells that can kill solid tumors.
Ep182: Andy Rachleff & Yung Lie on Creative Ways to Back Science
23/07/2025
1:01:18
Andy Rachleff and Yung Lie, board chair and CEO of Damon Runyon Cancer Research Foundation, on creative ways to support science amid budget cuts.
Ep181: Claire Mazumdar on a Two-Pronged Attack Against Cancer
01/07/2025
57:18
Claire Mazumdar, CEO of Boston-based Bicara Therapeutics, on developing a bifunctional antibody for head and neck cancer.

Plus d'épisodes

Découvrez le meilleur des podcasts sur l'application GetPodcast.

Abonnez-vous à tous vos podcasts préférés, écoutez les épisodes sans connexion internet et recevez des recommandations de podcasts passionnants.

Ep189: Marc Tessier-Lavigne on Reinventing Drug Discovery with AI

The Long Run with Luke Timmerman

D'autres épisodes de "The Long Run with Luke Timmerman"

Ep190: Neil Kumar on Building a Rare Disease Drug Company

Ep189: Marc Tessier-Lavigne on Reinventing Drug Discovery with AI

Ep188: Art Krieg on Innate Immune System Activators for Cancer

Ep187: Eric Fischer on Creating a New Class of Medicines

Ep186: Bruce Levine & Mags McCarthy on a Song About Science and Hope

Ep185: Dr. Lachelle Weeks on Predicting Leukemia Risk At Scale

Ep184: Jen Adair on Affordable, Accessible Gene & Cell Therapies

Ep183: Sabah Oney on CAR-T Cells Against Solid Tumors

Ep182: Andy Rachleff & Yung Lie on Creative Ways to Back Science

Ep181: Claire Mazumdar on a Two-Pronged Attack Against Cancer